Data from the transwell assay showed that after depletion of LCN2 in J7 or HepG2-TRα1 cells, migration abilities were decreased, compared with those of control cells (Fig. 4A, B, middle panel), confirming the ability of LCN2 to accelerate tumor cell migration in vitro. This evidence concerns the gene LCN2 and neoplasm.